Lupus Science and Medicine (Oct 2021)
Risk of psychiatric disorders and all-cause mortality with belimumab therapy in patients with systemic lupus erythematosus: a meta-analysis of randomised controlled trials
Abstract
No abstracts available.
Lupus Science and Medicine (Oct 2021)